Corcept Therapeutics, Inc. (CORT)
36.31
+1.02
(+2.89%)
USD |
NASDAQ |
Jan 21, 16:00
36.50
+0.19
(+0.52%)
After-Hours: 07:41
Corcept Therapeutics Cash from Investing (Quarterly): 14.64M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Axsome Therapeutics, Inc. | -0.058M |
| Johnson & Johnson | -- |
| United Therapeutics Corp. | 140.90M |
| Ultragenyx Pharmaceutical, Inc. | 117.18M |
| Amicus Therapeutics, Inc. | -1.299M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 54.48M |
| Cash from Financing (Quarterly) | -46.41M |
| Free Cash Flow | 162.57M |
| Free Cash Flow Per Share (Quarterly) | 0.4561 |
| Free Cash Flow to Equity (Quarterly) | 54.73M |
| Free Cash Flow to Firm (Quarterly) | 54.48M |
| Free Cash Flow Yield | 3.74% |